Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
98
self-reported 51–200 band
Founded
2001
25 years
Legal entities
None matched
Office countries
2
2 of 3 reported addresses
Funding rounds
6
Grant · Aug 2024 · US$ 13.4K
Company type
Public Company
self-reported
Description
Pacific Edge Limited (NZX/ ASX: PEB) is a global cancer diagnostics company leading the way in the development and commercialization of bladder cancer diagnostic and prognostic tests for patients presenting with hematuria or surveillance of recurrent disease. Headquartered in Dunedin, New Zealand, the company provides its suite of Cxbladder tests globally through its wholly owned, and CLIA certified, laboratories in New Zealand and the USA.
Cxbladder is a suite of non-invasive genomic urine tests optimized for the risk stratification of urothelial cancer in patients presenting with microhematuria and those being monitored for recurrent disease. The tests help improve the overall patient experience, while prioritizing time and clinical resources to optimize practice workflow and improve efficiency.
Supported by over 20 years of research, Cxbladder’s evidence portfolio extends to more than 25 peer reviewed publications, and Cxbladder Triage is now included in the American Urological Association’s Microhematuria Guideline. To drive increased adoption and improved patient health outcomes, Cxbladder is the focal point of numerous ongoing and planned studies designed to generate further clinical utility evidence.
Cxbladder is available in the US, Australasia, and Israel and in markets throughout Asia and South America. In the US, the test has been used by over 5,000 urologists who have ordered more than 130,000 tests. In New Zealand, Cxbladder is accessible to around 70% of the population via public healthcare and all residents have the option of buying the test online.
Learn more at www.cxbladder.com
Specialties
All 6 specialties
- cancer diagnostics
- genomic urine testing
- bladder cancer diagnostics
- molecular diagnostics
- cancer prognostics
- commercialisation
Locations
2
Countries with an office address3 reported addresses · 2 on record
New ZealandprimaryUnited States
Country footprint
Show as table · Offices in 2 countries
| Countries | 2 |
|---|---|
| Primary country | NZ |
All codes: NZ US
Addresses
- NZCentre for Innovation; 87 St David Street; Dunedin, Otago 9016Primary
- USHershey Center for Applied Research; 1214 Research Boulevard, Suite 2000; Hummelstown, PA 17036
Grid intelligence Members
Funding
Rounds6
Round typeGrant · non-equity funding
Amount (USD)13,400
Stage rank1
Investors named1
Since last round1 yr 5 mo
Funding
Show as table · 6 funding rounds
| Rounds | 6 |
|---|---|
| Axis | 2001 to 2026 |
| Grant · 19 Aug 2024 | US$ 13.4K |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
FAQ
How many people work at Pacific Edge Ltd?
The record holds 98 counted staff profiles at January 2026, inside the self-reported 51–200 band.
Where does Pacific Edge Ltd have offices?
Two addresses on record across 2 countries. Primary: Centre for Innovation, 87 St David Street, Dunedin, Otago 9016.
Has Pacific Edge Ltd raised funding?
Six rounds. Latest 19 August 2024: grant, US$13,400, investor Callaghan Innovation.
What does Pacific Edge Ltd list as its specialties?
Six tags on the brand's own list, among them commercialisation.
Which companies are listed alongside Pacific Edge Ltd?
10 profiles list Pacific Edge Ltd as a peer — 83rd percentile in Biotechnology. It lists ten peers of its own. BLIS Technologies Ltd. and Cancer Trials New Zealand list it back.